According to Precigen's latest financial reports the company's total assets are $0.15 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $0.21 B | -39.98% |
2021-12-31 | $0.35 B | 14.39% |
2020-12-31 | $0.31 B | -30.98% |
2019-12-31 | $0.45 B | -36.36% |
2018-12-31 | $0.71 B | -15.43% |
2017-12-31 | $0.84 B | -10.77% |
2016-12-31 | $0.94 B | -3.36% |
2015-12-31 | $0.98 B | 70.41% |
2014-12-31 | $0.57 B | 22.75% |
2013-12-31 | $0.46 B | 209.58% |
2012-12-31 | $0.15 B | 32.06% |
2011-12-31 | $0.11 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Organovo ONVO | $8.88 M | -94.12% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.20 B | 33.91% | ๐ฌ๐ง UK |
Novavax NVAX | $1.79 B | 1,090.05% | ๐บ๐ธ USA |
Novocure
NVCR | $1.14 B | 658.81% | Jersey |